ResearcherUniversity of PittsburghNo recent work listed
Jae Pil Jung
Matched on OpenAlex author ID A5110599046. Sources: OpenAlex.
Their work
- Papers
- 3
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 7
2019: 1 paper · 2020: 2 papers
Papers 3
- Serum CA19-9 Response to Neoadjuvant Therapy Predicts Tumor Size Reduction and Survival in Pancreatic Adenocarcinoma. Co-author DOI 10.1245/s10434-019-08156-3↗
- Correction to: Serum CA19-9 Response to Neoadjuvant Therapy Predicts Tumor Size Reduction and Survival in Pancreatic Adenocarcinoma. Co-author DOI 10.1245/s10434-020-08249-4↗
- Can post-hoc video review of robotic pancreaticoduodenectomy predict portal/superior mesenteric vein margin status in pancreatic adenocarcinoma? Co-author DOI 10.1016/j.hpb.2018.10.012↗
Closest collaborators
The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Melissa Ellen Hogg · 3 shared papers, 2019–2020 · strength 0.34
- Paper Serum CA19-9 Response to Neoadjuvant Therapy Predicts Tumor Size Reduction and Survival in Pancreatic Adenocarcinoma. DOI 10.1245/s10434-019-08156-3↗
- Paper Correction to: Serum CA19-9 Response to Neoadjuvant Therapy Predicts Tumor Size Reduction and Survival in Pancreatic Ad… DOI 10.1245/s10434-020-08249-4↗
- Paper Can post-hoc video review of robotic pancreaticoduodenectomy predict portal/superior mesenteric vein margin status in p… DOI 10.1016/j.hpb.2018.10.012↗
- Ahmad B. Hamad · 3 shared papers, 2019–2020 · strength 0.34
- Paper Serum CA19-9 Response to Neoadjuvant Therapy Predicts Tumor Size Reduction and Survival in Pancreatic Adenocarcinoma. DOI 10.1245/s10434-019-08156-3↗
- Paper Correction to: Serum CA19-9 Response to Neoadjuvant Therapy Predicts Tumor Size Reduction and Survival in Pancreatic Ad… DOI 10.1245/s10434-020-08249-4↗
- Paper Can post-hoc video review of robotic pancreaticoduodenectomy predict portal/superior mesenteric vein margin status in p… DOI 10.1016/j.hpb.2018.10.012↗
- Amer H. Zureikat · 3 shared papers, 2019–2020 · strength 0.34
- Paper Serum CA19-9 Response to Neoadjuvant Therapy Predicts Tumor Size Reduction and Survival in Pancreatic Adenocarcinoma. DOI 10.1245/s10434-019-08156-3↗
- Paper Correction to: Serum CA19-9 Response to Neoadjuvant Therapy Predicts Tumor Size Reduction and Survival in Pancreatic Ad… DOI 10.1245/s10434-020-08249-4↗
- Paper Can post-hoc video review of robotic pancreaticoduodenectomy predict portal/superior mesenteric vein margin status in p… DOI 10.1016/j.hpb.2018.10.012↗
- Herbert J. Zeh · 3 shared papers, 2019–2020 · strength 0.34
- Paper Serum CA19-9 Response to Neoadjuvant Therapy Predicts Tumor Size Reduction and Survival in Pancreatic Adenocarcinoma. DOI 10.1245/s10434-019-08156-3↗
- Paper Correction to: Serum CA19-9 Response to Neoadjuvant Therapy Predicts Tumor Size Reduction and Survival in Pancreatic Ad… DOI 10.1245/s10434-020-08249-4↗
- Paper Can post-hoc video review of robotic pancreaticoduodenectomy predict portal/superior mesenteric vein margin status in p… DOI 10.1016/j.hpb.2018.10.012↗
- Amr I. Al Abbas · 2 shared papers, 2020 · strength 0.24
- Paper Serum CA19-9 Response to Neoadjuvant Therapy Predicts Tumor Size Reduction and Survival in Pancreatic Adenocarcinoma. DOI 10.1245/s10434-019-08156-3↗
- Paper Correction to: Serum CA19-9 Response to Neoadjuvant Therapy Predicts Tumor Size Reduction and Survival in Pancreatic Ad… DOI 10.1245/s10434-020-08249-4↗
- Caroline J. Rieser · 1 shared paper, 2020 · strength 0.12
- Brian A. Boone · 1 shared paper, 2019 · strength 0.10
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.